Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
Smith AG, Singleton JR, Aperghis A, Coffey CS, Creigh P, Cudkowicz M, Conwit R, Ecklund D, Fedler JK, Gudjonsdottir A, Hauer P, Herrmann DN, Kearney M, Kissel J, Klingner E, Quick A, Revere C, Stino A; NeuroNEXT NN108 TopCSPN Study Team. Smith AG, et al. JAMA Neurol. 2023 Dec 1;80(12):1334-1343. doi: 10.1001/jamaneurol.2023.3711. JAMA Neurol. 2023. PMID: 37870862 Clinical Trial.
Suture removal by emergency department patients.
Ouellette L, Brown A, Nikroo N, Yassin S, Beasley K, Kraus N, Houseman J, Jones J. Ouellette L, et al. Among authors: houseman j. Am J Emerg Med. 2021 Jan;39:238-239. doi: 10.1016/j.ajem.2020.05.027. Epub 2020 May 16. Am J Emerg Med. 2021. PMID: 32461057 No abstract available.
"Robo-tripping": Dextromethorphan toxicity and abuse.
Ritter D, Ouellette L, Sheets JD, Riley B, Judge B, Cook A, Houseman J, Jones JS. Ritter D, et al. Among authors: houseman j. Am J Emerg Med. 2020 Apr;38(4):839-841. doi: 10.1016/j.ajem.2019.10.001. Epub 2019 Nov 17. Am J Emerg Med. 2020. PMID: 31812232 No abstract available.
Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence.
Nielsen S, Lintzeris N, Murnion B, Degenhardt L, Bruno R, Haber P, Johnson J, Hardy M, Ling S, Saddler C, Dunlop A, Demirkol A, Silsbury C, Phung N, Houseman J, Larance B. Nielsen S, et al. Among authors: houseman j. Drug Alcohol Rev. 2018 Nov;37(7):887-896. doi: 10.1111/dar.12859. Epub 2018 Oct 2. Drug Alcohol Rev. 2018. PMID: 30280448
39 results